About
FAQ
Reports
Contact Us
Works
Groups
People
Publications
Publishers
In Press
Advanced
Search Within
Isabelle C Riviere
Home
Works
Groups
Dashboard
"Hematologic Malignancies Research"
"Renier Brentjens"
"American Society of Hematology"
"2002"
Formats
Meeting Abstract (1)
Groups
Adult Leukemia (1)
Center for Hematologic Malignancies (1)
Department of Medicine (1)
GSK Faculty (1)
Hematologic Malignancies Research (1)
Hematologic Malignancies, Division of (1)
Adult Leukemia (1)
Center for Hematologic Malignancies (1)
Department of Medicine (1)
GSK Faculty (1)
Hematologic Malignancies Research (1)
Hematologic Malignancies, Division of (1)
Molecular Pharmacology and Chemistry Program Faculty (1)
Sloan Kettering Institute Faculty (1)
More Groups
Fewer Groups
People
Jean-Baptiste Latouche (1)
Michel Sadelain (1)
Renier Brentjens (1)
Years
2002 (1)
Publications
Blood (1)
Publishers
American Society of Hematology (1)
Results (1)
Export to
EndNote / Excel
|
PubMed
Show:
10
20
50
100
250
500
1000
2000
Sort By:
Author
Title
Year
Relevance
Created
Order:
Ascending
Descending
Style:
Nature
NLM
NIH-PMCID
Citation style sort is year ascending, and then by author or title. Author ascending is default.
In vivo anti-tumor activity of genetically modified T cells is dependent on the method of ex vivo T cell expansion
Meeting Abstract
Brentjens, R. J.
;
Latouche, J. B.
;
Riviere, I.
;
Sadelain, M.
Blood
(2002)
Fulltext@MSK
|
Save